Research only
All of alz.org
ALZ.ORG Research Center Alzheimer's Association International Conference ISTAART Journal Grants TrialMatch Press Donate Contact

Corporate Symposia - non-CME

Monday, July 14, 2014
6-8 p.m.
Latest Development With Diagnosis and Treatment of Alzheimer's Disease: Expert Consensus

Early diagnosis and effective treatment are critical to the optimal care of patients with Alzheimer's disease (AD). An international panel of AD experts will review the role of biomarkers in the diagnosis of AD as well as recent advances in treatment formulations that might improve outcomes in patients with AD.

CPD accredited by the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM).

Location
Crowne Plaza Hotel Copenhagen Towers
Grand Ballroom

RSVP

Sponsored by:
Symposium arranged by Medscape Education. This Medical Activity will be supported by independent
funding from Novartis Pharma AG.

 

 

Monday, July 14, 2014
6-7:30 p.m.
New Advances: Addressing Specific Nutritional Needs for Synapse Formation in Early Alzheimer's Disease

Synapse loss occurs early in Alzheimer's disease and is the best pathological correlate of memory impairment. Certain nutrients are critical for neuronal membrane synthesis, hence synapse formation, and there is evidence that these nutrients are lower in patients with AD. Souvenaid can address this imbalance and offer clinically relevant benefits.

Location
Bella Sky Hotel
Rooms 180/181

Sponsored by:
Nutricia Advanced Medical Nutrition

 

 

Monday, July 14, 2014
7-8:30 p.m.
New Symptomatic Approaches for the Treatment of Alzheimer's Disease: The Role of 5-HT6 Antagonists

In a challenging treatment development landscape, symptomatic approaches will be important in the future treatment of Alzheimer's disease. This symposium covers the scientific rationale for new symptomatic approaches, exemplified by 5-HT6 antagonists from preclinical and clinical perspectives.

Location
Hotel Scandic

RSVP

Sponsored by:
H. Lundbeck A/S & Otsuka Pharmaceutical Co., Lt

 

 

Tuesday, July 15, 2014
6-8 p.m.
The Future of AD Assessment and Diagnosis: Challenges? Solutions?

This educational symposium will explore the challenges and potential solutions facing earlier assessment and diagnosis of patients with AD. Can the current paradigm, “too little too late,” be changed? What are the most useful clinical assessment tools? What are the clinical and research implications of this paradigm shift?

Location
Bella Sky Hotel
Rooms 180/181

Sponsored by:
Eli Lilly and Company

 

 

Tuesday, July 15, 2014
6:30-9 p.m.
The Role of Beta-Amyloid Imaging: Implications for the Clinical Management of Early Cognitive Impairment

This thought-provoking symposium will examine diagnostic imaging methods currently used for the early detection and diagnosis of AD and MCI. Looking at case studies using neuroimaging agents, thought leaders will discuss the clinical and practical implications of positive and negative beta-amyloid PET scans.

Location
Crowne Plaza Hotel Copenhagen Towers
Grand Ballroom

RSVP

Sponsored by:
Piramal Imaging

 

 

Wednesday, July 16, 2014
6-8 p.m.
Targeting Key Pathologies in Alzheimer's Disease

Join your colleagues for an evening symposium that will address evolving strategies and next-generation therapeutic approaches in the global fight against dementia. Biogen Idec — a company dedicated to the development of innovative therapies for neurodegenerative diseases — is proud to be a first-time supporter of this program at AAIC.

Location
Crowne Plaza Hotel Copenhagen Towers
Grand Ballroom

RSVP

Sponsored by:
Biogen Idec

 

 

Wednesday, July 16, 2014
6-8 p.m.
Bringing Clarity to Functional Imaging in the Progression of Dementia

Join the debate on beta-amyloid pathology and imaging in Alzheimer's disease. The symposium will cover the challenges of diagnosis at all points on the dementia spectrum and the clinical impact of new imaging techniques. This interactive mini-symposium is supported by GE Healthcare.

Location
Bella Sky Hotel
Rooms180/181

RSVP

Sponsored by:
GE Healthcare

 

 



back to top
Where the world reveals the latest dementia research • Washington, D.C., United States • July 18-23, 2015